AmniSure

Curated by Signal

Provider of home test for detecting the different stages of pregnancy

Overview

Amnisure, part of Qiagen, offers a home test for detecting the different stages of pregnancy. The test has antibodies that can detect placental alpha microglobulin-1 (PAMG-1) in the cervical-vaginal secretions after the rupture of the membranes. The test thereby helps in indicating prenatal and postnatal complications. The test is lateral flow based.

Key facts

Founded: 2007
Headquarters: Moscow, Russia
Stage: Sign up to view
Industry: Life Sciences Technology

Business model

1 product or service: Sign up to view

Contact

Email: Sign up to view
Phone: Sign up to view

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Life Sciences Technology companies

Denti.AI
Provider of automated diagnostics of dental images
Life Sciences TechnologySaint Petersburg, Russia
Medicom MTD
Medical equipment for electrodiagnosis, epileptology, somnology, rehabilitation and research
Life Sciences TechnologyTaganrog, Russia
Ugene
Developer of integrated bioinformatics tools
Life Sciences TechnologyNovosibirsk, Russia

About AmniSure

What does AmniSure do?

Amnisure, part of Qiagen, offers a home test for detecting the different stages of pregnancy.

Where is AmniSure headquartered?

AmniSure is headquartered in Moscow, Russia.

When was AmniSure founded?

AmniSure was founded in 2007.

Which sector is AmniSure in?

AmniSure operates in Life Sciences Technology.

Who are AmniSure's competitors?

Companies similar to AmniSure include Denti.AI, Medicom MTD, and Ugene.